Calendar MiNK Therapeutics, Inc.

Equities

INKT

US6036931029

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.9275 USD +6.46% Intraday chart for MiNK Therapeutics, Inc. +5.84% -13.32%

Chart calendar MiNK Therapeutics, Inc.

c9.Yd5Fj6BOeZOlK9aqJ1H4tzzg_ayeCxp8tflWdDdxamU.Fa4kvvgPMKvxe4LlQ2io6Guyiub4YDcL8JQsHUQhByYy7jC28QVA0dcG5g~3038936811c9b27cb19062605974b578

Upcoming events on MiNK Therapeutics, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-03-18 Q4 2024 Earnings Release (Projected)

Past events on MiNK Therapeutics, Inc.

2024-04-08 12:00 pm American Association for Cancer Research Meeting - Abstract Number: 1331
2024-03-21 08:30 am Q4 2023 Earnings Call
2024-03-21 07:00 am Q4 2023 Earnings Release
2023-11-09 08:30 am Q3 2023 Earnings Call
2023-11-09 07:00 am Q3 2023 Earnings Release
2023-10-31 Society for Immunotherapy of Cancer Meeting - Abstract Number: 735
2023-09-13 02:30 pm H.C. Wainwright Global Investment Conference - Fireside Chat
2023-09-12 12:15 pm Baird Global Healthcare Conference - Fireside Chat
2023-08-10 07:30 am Q2 2023 Earnings Release
2023-08-08 11:30 am BTIG Virtual Biotechnology Conference
2023-06-13 10:30 am Annual General Meeting
2023-05-20 American Thoracic Society International Conference - Abstract Number : 10725
2023-05-19 12:00 pm American Society of Gene Cell Therapy Meeting - Abstract No: 1488
2023-05-11 08:30 am Q1 2023 Earnings Call
2023-05-11 08:00 am Q1 2023 Earnings Release
2023-04-20 10:00 am Investor Meeting - Key Opinion Leader
2023-04-18 01:30 pm American Association for Cancer Research Meeting - Abstract Number: CT275
2023-03-21 08:30 am Q4 2022 Earnings Call
2023-03-21 08:00 am Q4 2022 Earnings Release
2023-02-28 09:00 am H.C. Wainwright Cell Therapy Virtual Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-28,4
-32,9
13.84%
-30,9
-31,4
1.48%
-22,9
-23,0
0.14%

-22,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
-22,5
-22,3
-0.7%

-19,1

Net income
Million USD
Released
Forecast
Spread
-16,2


0,00
0,00
-
-28,0
-32,0
12.45%
-22,5
-24,8
9.36%

-19,1

EPS
USD
Released
Forecast
Spread
-1,87


0,00
0,00
-
-0,83
-0,89
6.74%
-0,65
-0,66
2.01%

-0,52

Announcement Date14/09/2118/03/2221/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-6,36
-10,9
41.72%
-7,37
-7,37
-0%
-7,70
-7,56
-1.83%
-7,99
-8,23
2.98%
-7,89
-8,35
5.57%
-5,85
-8,17
28.37%
-6,34
-6,59
3.8%
-5,22
-6,48
19.45%
-5,50
-5,37
-2.5%

-5,40


-5,07


-5,59


-5,95


-6,77

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread















-5,69
-8,09
29.71%
-6,20
-6,21
0.15%
-5,12
-6,08
15.86%
-5,46
-5,30
-2.92%

-5,07


-4,27


-4,75


-4,98


-6,73

Net income
Million USD
Released
Forecast
Spread












-7,77
-8,91
12.81%
-5,69
-8,19
30.54%
-6,20
-6,55
5.37%
-5,12
-6,67
23.26%
-5,46
-5,30
-2.92%

-5,07


-4,27


-4,75


-4,98


-6,80

EPS
USD
Released
Forecast
Spread












-0,23
-0,21
-9.52%
-0,17
-0,24
29.17%
-0,18
-0,19
6.89%
-0,15
-0,17
13.46%
-0,15
-0,15
0%

-0,15


-0,12


-0,13


-0,13


-0,14

Announcement Date18/03/2213/05/2209/08/2203/11/2221/03/2311/05/2310/08/2309/11/2321/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. INKT Stock
  4. Calendar MiNK Therapeutics, Inc.